gene de-repression and to unscheduled differentiation. Here we show that Jarid2 is a novel subunit of PRC2 that is required for the co-recruitment of PRC1 and RNAP to genes that regulate development in ES cells. Jarid2-deficient ES cells showed reduced H3K4me2/me3 and H3K27me3 marking and PRC1/PRC2 recruitment, and did not efficiently establish Ser 5-phosporylated RNAP at target genes. ES cells lacking Jarid2, in contrast to previously characterized PRC1 and PRC2 mutants, did not inappropriately express PRC2 target genes. Instead, they show a severely compromised capacity for successful differentiation towards neural or mesodermal fates and failed to correctly initiate lineage-specific gene expression in vitro. Collectively, these data indicate that transcriptional priming of bivalent genes in pluripotent ES cells is Jarid2-dependent, and suggests that priming is critical for subsequent multi-lineage differentiation.
In undifferentiated ES cells, many genes that encode transcription factors that are required for subsequent stages of development are enriched with histones modified simultaneously for active transcription (H3K4me2/ me3) and PRC2-mediated repression (H3K27me3) [1] [2] [3] [4] . It has been suggested that this chromatin profile-often referred to as bivalent-serves to prime undifferentiated cells to respond rapidly to lineage induction [5] [6] [7] . Although there is a paucity of experimental data to validate or refute this idea, reports have shown evidence of transcriptional priming in ES cells, as well as other cell types [8] [9] [10] . Importantly, RNAP is enriched at many PRC1/PRC2 target genes in mouse ES cells in a Ser 5-phosphorylated form that is 'poised' but inhibited (at least in part) by PRC1-mediated H2Aub1, and fails to efficiently elongate or produce mature transcripts 8 . Experimental removal of PRC1 or PRC2 in ES cells leads to gene derepression in vitro [2] [3] [4] 8, [11] [12] [13] , and early embryonic lethality in vivo [14] [15] [16] [17] . Although these data show that bivalent genes are poised for expression in ES cells, they do not address whether transcriptional priming is central to the core biological properties of ES cells to self-renew and execute multi-lineage differentiation.
To identify PRC2-interacting proteins in mouse ES cells we used mass spectroscopy, and generated an ES cell line that stably expressed amino-terminal 2×Flag-tagged Eed isoform 3 as bait. Western blot analysis confirmed that expression of 2×Flag-Eed in these cells was moderate, and did not substantially elevate overall Eed levels ( Supplementary  Information, Fig. S1a ). Flag antibodies immunoprecipitated proteins with the expected sizes of PRC2 core components from 2×Flag-Eedtransfected, but not parental, ES cells (Fig. 1a) . Mass spectrometry of 1 the immunoprecipitated material confirmed the presence of PRC2 core components, and in addition, showed that Jarid2 and Pcl2 were present in abundance (Fig. 1a) .
To verify that Jarid2 associates with the PRC2 complex in vivo, we generated 2×Flag-Jarid2 ES cells. Immunoprecipitation with Flag antibodies from 2×Flag-Jarid2 ES cells showed bands, not seen in samples from parental ES cells, with the expected sizes of the PRC2 core members Eed, Ezh2 and Suz12, in addition to 2×Flag-Jarid2 (Fig. 1b) . Mass spectrometry of the immunoprecipitated material confirmed the presence of Suz12, Ezh2 and Eed, as well as Aebp2 (Fig. 1b) ; a zinc-finger protein that has been reported to enhance H3K27 methylation activity by PRC2 (ref. 18 ). Ezh1 and Pcl2 were readily co-immunoprecipitated with Eed (Fig. 1a ), but not with Jarid2 (Fig. 1b) , suggesting that Jarid2 and Ezh1/Pcl2 reside in distinct PCR2 sub-complexes. To confirm that Jarid2 interacts with Eed in vivo, we immunoprecipitated endogenous Eed from wild-type ES cells. Western blotting demonstrated that Eed co-immunoprecipitated Jarid2 as well as Ezh2 and Suz12 (Fig. 1c) . Interaction between Jarid2 and PRC2 components persisted in the presence of ethidium bromide, suggesting that it was direct and not mediated by DNA. The reverse immunoprecipitation experiment in 2×Flag-Jarid2 ES cells confirmed that 2×Flag-Jarid2 interacts with Ezh2, Suz12 and Eed (particularly isoform 3) (Fig. 1d) . These data indicate that Jarid2 is a component of PRC2 in ES cells.
The genomic targets of Jarid2 in mouse ES cells were identified by chromatin immunoprecipitation followed by genomic tiling arrays (ChIP-chip). These contained regions of 200 kilobases (kb) to 2 megabases (Mb) surrounding 120 selected loci, and a contiguous section of mouse chromosome 17 (approximately 3% of the unique sequence content of the mouse genome covering 1,098 annotated genes 19 ). Flag-ChIP showed localization of Jarid2 to 626 sites (false discovery rate 5%), of which 109 mapped within 1 kb upstream of transcription start sites (TSS) at promoter regions (< 1 kb upstream of TSS). This represents a 12-fold preference of Jarid2 for 5ʹ upstream sequences, compared with other regions of the genome (P = 2.2 × 10 -16 , chi-squared test). More than 90% of promoters bound by Jarid2 were also associated with PRC2 components (Eed/Suz12) and/or enriched in H3K27me3, based on comparison with published tiling array data 2 covering 97 of these promoters (Fig. 1e) . Binding of histone H3K27me3 or H3K4me2 had been reported for 81 of our Jarid2 targets 20 , and 70 of these were marked by both H3K27me3 and H3K4me2. This represents a striking preference of Jarid2 for bivalent promoters (P = 2.31 × 10 -62 , chi-squared test; Fig. 1f ). Jarid2 also showed a significant preference for promoters with high CpG density and was underrepresented at promoters with low CpG content (P = 6.15 × 10 -6 , chi-squared test; data not shown). Flag-ChIP of 2×Flag-Jarid2 followed by quantitative PCR (qPCR) confirmed binding of Jarid2 to each of seven , chi-squared test) preference of Jarid2 for bivalent (K4+K27+) promoters.
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6 1 9 bivalent promoters tested ( Supplementary Information, Fig. S1b ). For three bivalent loci (Dach1, Sox7 and Nkx2-2) we profiled binding over a larger region around the TSS and found that Jarid2 recapitulated the profile of H3K4me2 enrichment ( Supplementary Information, Fig. S1c ). Thus, genome-scale analysis of Jarid2 targets shows a highly significant overlap between Jarid2 and PRC2 at the promoters of bivalent genes in mouse ES cells.
To probe the effect of Jarid2 on histone methylation levels, we transfected HEK293T cells with Jarid2 ( Supplementary Information, Fig. S1d ) and found H3K4me2/3 levels unchanged ( Supplementary Information,  Fig. S1e) . As a control, overexpression of the H3K4-specific demethylase JARID1A (RBP2; Supplementary Information, Fig. S1d ) resulted in significantly reduced methylation levels ( Supplementary Information, Fig.  S1e ). H3K9 methylation was unaffected by both Jarid2 and RBP2 overexpression and Jarid2 did not measurably affect H3K27me3, H3K36me2 and H4K20me2/me3 levels ( Supplementary Information, Fig. S1e ), suggesting that Jarid2 is not catalytically active in these assays.
Jarid2 heterozygous ES cells were obtained through the knockout mouse project (KOMP), and we generated homozygous mutant Jarid2 cells by targeting the second allele ( Supplementary Information,  Fig. S2a ). Long-range PCR confirmed that heterozygous (A08) and homozygous Jarid2-knockout lines (E4 and E8) contained one-or twotargeted Jarid2 alleles, respectively ( Supplementary Information, Figures  S2a, S2b) . Western blotting showed that Jarid2 protein was reduced in Jarid2 +/-and undetectable in Jarid2 -/-samples relative to wild-type (Fig. 2a) . Jarid2 -/-cells retained normal levels of Oct4 protein (Fig. 2a) , Oct4, Sox2 and Nanog transcripts, and expressed similar levels of PRC2 components ( Supplementary Information, Fig. S2c, d ). Jarid2 -/-ES cell colonies showed similar levels of alkaline phosphatase activity as controls ( Supplementary Information, Fig. S2e ), although Jarid2-deficient and -null lines had a more dispersed appearance (Fig. 2b) . Jarid2-deficient ES cells grew faster (Fig. 2c) , and when plated at low density generated more colonies than wild-type (Fig. 2d) . Assessment of cell-cycle phases using propidium iodide labelling ( Supplementary Information, Fig.  S2f) showed that Jarid2
+/-and wild-type cells all had broadly similar profiles; immunofluorescence labelling confirmed that most cells within these cultures remained undifferentiated and expressed Oct4 (> 95%, Supplementary Information, Fig. S2g ) and SSEA1 (> 99%, data not shown). These results show that Jarid2-deficient ES cells retain pluripotency markers and have enhanced growth and cloning efficiencies without marked disturbance in cell-cycle progression.
ES cells lacking individual PRC2 components inappropriately express PRC2 target genes and are prone to unscheduled differentiation [2] [3] [4] 11, 13, 21 . To investigate whether Jarid2 has a similar repressive function we examined transcript levels in wild-type, Jarid2
+/-and Jarid2 -/-ES cells, using reverse transcription quantitative PCR (RT-qPCR) and Eed -/-ES cells as controls. In contrast to Eed -/-ES cells ( Fig. 2e ; blue), Jarid2-deficiency did not result in derepression of most of the PRC2 target genes tested (Fig. 2e) , including those bound by Jarid2 ( Supplementary Information,  Fig. S1b ). Jarid2-deficient cells tended to express even lower levels of most of these genes than parental cells. These results suggest that Jarid2, unlike the PRC2 components Eed, Suz12 and Ezh2, is not essential for PRC2-mediated gene repression in ES cells.
To determine whether Jarid2 is important for the recruitment of PRC1 and PRC2 components to target genes in ES cells we performed ChIP analysis. Jarid2-deficient ES cells showed reduced binding of Ezh2 and Suz12 to the promoters of each of seven PRC2 target genes tested (Mash1, Wnt1, Pax3, Nkx2-2, Sox7, Dach1 and Sox1) (Fig. 3a) , and at the Nkx2-2 locus ( Fig. 3b; Supplementary Information, Fig. S3 ); an extensively characterized bivalent domain 8 . H3K27me3, H3K4me2 and H3K4me3 levels at each of these loci were diminished in Jarid2-deficient ES cells, compared with wild-type ( Figure S3 , is plotted as a function of distance to TSS (error bars are shown in Supplementary Information, Fig. S3 ). Experiments were performed using wild-type (JM8, black), heterozygous (A08, grey) and Jarid2-knockout ES cells (E4, E8, white bars or E4; red and E8; blue lines). A scheme of the Nkx2-2 locus displaying TSS (arrow) and three exons (black boxes) is shown in b. Ccnd1, a putative Jarid2 target gene in cardiac myocytes 29 , and Oct4, Hprt and Myf5 were included as controls.
As PRC1 is thought to mediate the silencing of many PRC2 target genes, it was surprising that PRC2 targets are not de-repressed in ES cells lacking Jarid2. Lack of de-repression could not be ascribed to increased DNA methylation, as bisulphite sequencing of five PRC2 target genes (Sox30, Pax5, Hoxa10, Irx3 and Math1) showed no appreciable differences between Jarid2 -/-and wild-type ES cells ( Supplementary Information, Fig. S4 ). We therefore examined alternative mechanisms to explain the continued transcriptional inactivity of PRC2 target genes in Jarid2-deficient ES cells. H2Aub1, the histone modification catalysed by the PRC1 complex was reduced in Jarid2 -/-cells ( Supplementary Information, Fig. S5a ), although this was less striking than the decrease of Ring1B and Mel18.
In wild-type ES cells RNAP is engaged at PRC2 target gene promoters 8, 9 , but shows an unusual set of post-translational modifications 22 in which high levels of phosphorylated Ser 5 are present, but detection of phosphorylated Ser 2 and reactivity with 8WG16 (an antibody that preferentially recognizes non-phosphorylated Ser2 residues of RNAP) is low. Consistent with this, phosphorylated Ser 5 RNAP was abundant at the promoters of actively expressed genes (such as Hprt, Oct4 and Ccnd1) and PRC2-target genes in wild-type ES cells (Fig. 4b , black bars, upper panel). In striking contrast, only low levels of phosphorylated Ser 5 RNAP were detected in Jarid2 -/-ES cells at six of seven PRC2 target genes and across the Nkx2-2 locus ( Fig. 4b; Supplementary Information, Fig. S5a ). As expected, hypophosphorylated RNAP was detected at active genes (Hprt, Oct and Ccnd1) in both wild-type and Jarid2-deficient ES cells (Fig. 4b, lower  panels) , but was not detected at silent (Gata1 and Myf5) or bivalent 23 , was detected at the promoters of expressed and bivalent genes in Jarid2-deficient and wild-type ES cells ( Supplementary Information,  Fig. S5b ). These data reveal a defect in recruiting phosphorylated Ser 5 RNAP to PRC2 target genes in Jarid2-deficient ES cells, and provide evidence that Jarid2 is critical for the transcriptional priming of these genes in ES cells.
Jarid2 expression is dependent on the triad of transcription factors Oct4, Sox2 and Nanog, and is downregulated upon ES cell differentiation [24] [25] [26] . Consistently with this, Jarid2 was downregulated when wild-type ES cells were induced to differentiate into neuronal cells or mesoderm ( Supplementary Information, Fig. S6 ). In contrast to wildtype ES cells, Jarid2 -/-ES cells were unable to differentiate efficiently in response to withdrawal of leukaemia inhibitory factor (LIF), neural induction (Fig. 5a ) or mesoderm induction (Fig. 5b) . Differentiation of Jarid2 -/-ES cells towards Flk1-expressing hemangioblasts 27 was also severely compromised (Fig. 5b, lower panel) . Jarid2-deficient cells formed only rudimentary embryoid bodies, which, in contrast to wild-type embryoid bodies, continued to express Oct4 and Nanog protein and failed to express Nestin (Fig. 5c) . Jarid2 +/-cells showed an intermediate phenotype, with a partial downregulation of Oct4 and Nanog and delayed induction of Nestin (Fig. 5c) . Similarly, Dach1, Irx3, Wnt1, Mash1 and Pax3 transcripts were upregulated on neural induction of wild-type (Fig. 5d, black bars) , but not in Jarid2 -/-ES cells (Fig. 5d, white bars) . These data show that Jarid2 is important for the successful execution of multiple differentiation pathways.
Jarid2 is essential for mouse development 28, 29 , and is a recognized component of pluripotency networks [24] [25] [26] . Recently, Jarid2 was shown to associate with the PRC2 complex in ES cells and to occupy many polycomb targets genome-wide [30] [31] [32] [33] . These reports have suggested that Jarid2 modulates H3K27me3 levels in ES cells through PRC2 recruitment, but have offered contradictory views on whether Jarid2 inhibits 30, 31 or stimulates 32, 33 PRC2 histone methyltransferase activity. Our data show that in the absence of Jarid2, PRC2-target genes in ES cells show modest reductions in both H3K27me3 and H3K4me2/3 levels, a corresponding reduction in PRC1 recruitment and rather mild effects on downstream H2Aub1. Perhaps the most surprising observation is that ES cells lacking Jarid2 failed to efficiently establish 'initiating' Ser 5 RNAP at PRC2 target genes. In wild-type ES cells, where PRC1 and Ser 5 RNAP are bound at many PRC2 targets 2, 8 , withdrawal of Eed, Suz12, Ezh2 or Ring1A/B results in the de-repression of target genes [2] [3] [4] 8, [11] [12] [13] . In Jarid2-deficient ES cells a functionally 'poised' or 'primed' state is clearly not established, a point that is reinforced by the finding that expression of PRC2 target genes in Jarid2-depleted ES cells is actually lower than the basal transcript levels detected in wild-type ES cells. In addition, we have shown that Jarid2-deficient ES cells are unable to efficiently differentiate to mesoderm or neural lineages in vitro but exhibit enhanced proliferation when maintained in conditions that support the undifferentiated state. The compromised differentiation of Jarid2-deficient ES cells described here is similar to recently reported deficits in 'cell fate transition' and lineage induction reported for Jarid2 knockout 31 or Jarid2-shRNA-treated (knockdown) ES cells 33 . Our data, showing that in the absence of Jarid2 important development regulator genes in ES cells are not efficiently primed, may provide an explanation for the failure of these cells to respond in a timely and appropriate way to developmental cues. The requirement for Jarid2 during ES cell differentiation is particularly intriguing as ES cells normally downregulate Jarid2 expression soon after the onset of differentiation. This suggests that Jarid2 has a critical role in undifferentiated ES cells either in preserving their multi-lineage potential status or in mediating the successful switching of ES cells from a proliferative to a differentiating state. The fact that Jarid2 is also required to efficiently establish a poised RNAP configuration at PRC2 targets in ES cells provides further evidence that transcriptional priming of key regulators is important for pluripotent function. 
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Generation of Flag-fusion-expressing cell lines. Jarid2 and Eed isoform 3 cDNA were cloned from OS25 ES cell mRNA using oligonucleotides: 5ʹ-GGA TCC ATGTCCGAGAGGGAAGTGTCG-3ʹ 5ʹ-GA ATTC T TATCG-AAGT CGATCCCATCGC-3ʹ for Eed and 5ʹ-TGATCA ATGAGCAA GGA AAG-ACCCAAG-3ʹ and 5ʹ-TCTAGATCA TGAGGATGGGAGCCG-3ʹ for Jarid2.
cDNA was cloned into 2×FlagpCDNA3 through BamHI/EcoRI (Eed) and BamHI/XbaI (Jarid2) restriction sites. cDNA from 2×Flag-Eed and 2×Flag-Jarid2 cells was excised and cloned into the chicken β-actin promoter-driven expression vector pCBA 36 and used to stably transfect E14 (2× Flag-Jarid2) and Ezfl (2×Flag-Eed) murine ES cell lines using Lipofectamine 2000 (Invitrogen) and G418 selection (300 μg ml -1 for 6 days). ES cells were cultured on gelatin coated dishes in the presence of LIF at 37 °C and 5% CO 2 . Eed expression by 2×Flag-Eed ES cells is shown in Supplementary Information, Figure S1a . Jarid2 expression by 2×Flag-Jarid2 ES cells was modestly increased over endogenous levels (~20%, data not shown).
Immunoprecipitation and Mass Spectrometric analysis. Immunoprecipitation, silver staining and mass spectrometric analysis were carried out as described 37 with the following antibodies: mouse anti-Eed (A. Otte, University of Amsterdam, NL), mouse anti-Flag (Sigma) and mouse IgG (Santa Cruz Biotechnology).
Jarid2 and RBP2 expression in HEK293T cells. HEK293T cells were transiently transfected with pCDNA3 (Invitrogen), pCDNA3 containing 2×Flag-Jarid2 (as above) or human RBP2 cDNA, using calcium phosphate.
Western blot analysis. Western blots were carried out using the following antibodies: rabbit antisera to Jarid2 (1:1,000) (Abcam or Y. Lee, University Wisconsin, USA), histone H3 (1:30,000; Abcam), H3K4me3 (1:1,000; Abcam), H3K4me2 (1:1,000; Millipore), H3K36me3 (1:1,000; Abcam), H3K9me3 (1:1,000; Millipore), H3K9me2 (1:1,000; Diagenode), H3K36me2 (1:1,000; Millipore), H3K27me3 (1:1,000; Millipore), H4K20me3 (1:1,000; Abcam), H4K20me2 (1:1,000; Millipore), Suz12 (1:1,000; Diagenode), Ezh2 (1:1,000; Millipore) and Nanog (1:200; Cosmo Bio Co.); mouse antibodies to Eed (1:2,000; A. Otte), Nestin (1:500; BD Biosciences) and Flag (1:1000; Sigma) and goat antibodies to LaminB (1:30,000; Santa Cruz Biotechnology) and Oct4 (1:5,000; Santa Cruz Biotechnology). Secondary species-specific antibodies were anti-goat-HRP (Santa Cruz), anti-mouse-HRP (GE Healthcare) and anti-rabbit-HRP (GE Healthcare). For detection Amersham ECL Plus (GE Healthcare) was used.
2×Flag-Jarid2 ChIP-on-chip analysis. Cells were fixed in PBS in 1% para-formaldehyde (15 min, 25 °C), quenched with 125mM glycine and lysed in a solution containing 5mM PIPES at pH 8.0, 85mM KCl and 0.5% NP-40 for 20 min at 4 °C. After spinning, nuclei were resuspended in a solution containing 1% SDS, 10mM EDTA at pH 8.0 and 50mM Tris at pH 8.1, diluted 1:1 in radio immunoprecipitation assay (RIPA) buffer, and sonicated until DNA fragment size was 0.2-2 kb. Flag M2 antibody (25 μg; Sigma) and Protein-G-Dynabeads (Invitrogen) were used. Elution was performed with 250 μl of RIPA buffer containing 0.05 mg of 3×Flag peptide (Sigma). Reverse crosslinked DNA was purified using QIAquick spin columns and eluted in 60μl Buffer EB (Qiagen). ChIP samples were amplified according to manufacturer's instructions (Nimblegen) for hybridization to custom tiling arrays with 380,000 features at 100 bp resolution, and results were analysed using Tilemap software. The comparison with the Mohn et al. data set 20 was based on chromosomal coordinates available at (http://www.fmi.ch/groups/schubeler.d/ web/supplements/Mohn_2008_promoters.txt) after conversion from mm8 (NCBI build 36) to mm5 (NCBI build 33) by using the UCSC LiftOver tool.
Histone modifications, polycomb proteins and RNAP ChIP analysis. ChIP experiments for methylated histones were performed as described above with the following modifications. For each immunoprecipitation, 100 μg of chromatin was incubated with 10 μg of one of the following antibodies: anti-H3 (Abcam), anti-H3K4me2 (Millipore), anti-H3K4me3 (Abcam), anti-H3K27me3 (Millipore) and Protein A-Dynabeads (Invitrogen). ChIP experiments of Ezh2 and Suz12 were performed as above, but the cells were fixed in medium with 1% paraformaldehyde for 10 min and using 10 μg of anti-Ezh2 (Diagenode) and anti-Suz12 (Cell signaling), respectively. ChIP experiments for H2Aub1, Mel18, Ring1B and Tbp were performed using conditions previously described 8 and anti-ubiquityl-Histone H2A (Millipore), antiMel18 (Santa Cruz), anti-Ring1B (MBL) or anti-TBP (Santa Cruz), respectively, and ProteinA/G-Dynabeads (Invitrogen). ChIP experiments for phosphorylated Ser 5 and 8WG16 RNAP were performed using anti-RNAP CTD4H8 (Covance) or Ms 8WG16 (Covance), respectively, as described previously 8 with the following modifications. Magnetic beads (Active Motif) were incubated with rabbit anti-mouse antibodies (Jackson Immunoresearch; 10 μg per 50 μl of beads) for 1 h at 4 °C and washed with sonication buffer. Chromatin (700 μg, determined by measuring absorbance of alkaline-lysed, crosslinked chromatin) was immunoprecipitated (overnight at 4 °C) with 10 μl antibody and 50 μl of beads (with bridging antibody). Immunoprecipitated DNA of the different ChIP experiments was analysed using real-time PCR 4 . Primer sequences are available upon request.
Gene expression analysis by RT-qPCR. RNA was isolated using the RNeasy Kit (Qiagen), reverse transcribed using SuperScriptIII as recommended by the manufacturer (Invitrogen) and analysed by real-time PCR using Quantitect SYBR green PCR kit (Qiagen), as described previously 4 . Primer sequences are available upon request.
Jarid2 KO ES targeting, genotyping and cell culture. Feeder-free adapted parental JM8 (wild-type) mouse ES cells are derived from the C57BL6/N mouse strain 38 . Jarid2 mutant mouse embryonic stem (mES) cell lines were obtained using targeted genetrapping approaches 39 . JM8 and Jarid2 heterozygous mutant mES cells were generated by the Wellcome Trust Sanger Institute's knockout mouse project (http://www.komp. org) production center (W.C. Skarnes, et al., manuscript in preparation). The Jarid2 heterozygous mutant 'KO first' allele contains a standard β-geo trapping cassette targeted by replacement mutagenesis into the intron 1-2. Jarid2 homozygous mutant mES cell lines were generated using an insertion type vector containing a hygromycin resistance gene, an enhanced GFP marker, and a poly(A) sequence in a gene trapping cassette that targets intron 2-3. Further details on the second allele targeting strategy will be published elsewhere (C. Fisher and W.C. Skarnes, in preparation). Correct targeting of the first allele was reconfirmed by genomic long-range PCR (LRPCR) using the gene-specific primer: 5ʹ-AGGTATTTTGTTCGCCGTGTGTTTC-3ʹ and the vector-specific primer: 5ʹ-GCCTCTTCGCTATTACGCCAGCTG-3ʹ. Correct targeting of the second allele was reconfirmed by LRPCR using the gene-specific primer: 5ʹ-TCTTTCTGTGCCTTGTTCTGACCTG-3ʹ and the vector-specific primer: 5ʹ-GCAGCTATTTACCCGCAGGA-3ʹ. PCR reactions were performed using the 'Expand Long Template' PCR system (Roche).
Alkaline phosphatase activity was determined using alkaline phosphatase kit (Sigma). Cell-cycle profile was analysed by staining ice-cold ethanol fixed cells with propidium iodide followed by analysis with FACSCalibur (Beckton Dickinson). Oct4 immunofluorescence analysis was carried out using Ms antiOct3/4 (BD bioscience) antibody.
ES cell culture and differentiation. Bry201 ES cells (V. Kouskoff, University of Manchester, UK) were maintained and differentiated as described elsewhere 27 . Differentiation of JM8 and Jarid2-deficient ES cells was induced by LIF withdrawal in monolayer cultures (5 × 10  3 cells per cm   2 , plated on gelatinized flasks in ES medium). Monolayer differentiation towards neural lineage in serum-free neural differentiation medium N2B27 (Stem Cell Sciences) was carried out as described previously elsewhere 34 . Monolayer differentiation to mesoderm was carried out as described 35 . For embryoid body differentiation, 7 × 10 6 cells were plated in non-adherent plates in ES cell medium without LIF. To obtain mesoderm-enriched embryoid bodies, cells were differentiated as described elsewhere 27 . At 3.75 days of differentiation EBs were stained for FACS analysis using PE-Flk1 antibody (BD Bioscience,).
Bisulphite genomic sequencing. Bisulphite genomic sequencing was carried out as described previously 40 with oligonucleotides detailed in Supplementary Information, Table S1 .
Statistical analysis. Statistical significance of PCR and ChIP-chip experiments was determined by applying a one-tailed Student's t-test to raw enrichment values and Chi-squared test, respectively. 
